USJ Stock Chart & Stats
€10.90
-€2.60(-16.88%)
At close: 4:00 PM EDT
€10.90
-€2.60(-16.88%)
Day’s Range― - ―
52-Week Range€10.50 - €26.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€241.27M
Enterprise Value€273.74
Total Cash (Recent Filing)€168.56M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta0.63
Next Earnings
Oct 27, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.21
Shares Outstanding18,476,534
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.46
Price to Book (P/B)0.68
Price to Sales (P/S)0.39
P/FCF Ratio42.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.83
Revenue Forecast (FY)€817.79M
Bulls Say, Bears Say
Bulls Say
Debt-free Balance Sheet And Cash GenerationUSANA's debt-free balance sheet and substantial cash reserve provide resilience while profitability is pressured. Positive free cash flow gives management capacity to fund product development, retail expansion, and other strategic investments without relying heavily on external financing.
Product Innovation And Retail DistributionRecent product launches are expanding USANA's consumer reach beyond its traditional direct-selling base. GLOW adds a new skin-health category, while Protein Pop's national retail presence supports broader distribution and creates additional avenues for recurring product sales.
Core Nutrition Stability And China MomentumThe core nutrition business remains an important stabilizing platform, with China showing renewed momentum supported by launches and incentives. This suggests established brands and distributor engagement can still support recovery in a strategically important market.
Bears Say
Severe Profitability DeteriorationThe collapse in operating profitability and move to a TTM net loss weaken earnings quality despite strong gross margins. Persistently low EBIT leaves little buffer for marketing, tax, or operating pressures and limits the cash available to reinvest in growth.
Declining Sales And Customer BaseLower sales alongside contraction in both core customers and Hiya subscribers indicates pressure on the recurring demand engine across multiple business areas. Reduced scale can worsen operating leverage and make a durable recovery in revenue and margins more difficult.
Hiya Marketing Economics And Guidance PressureHiya's direct-to-consumer model is facing a more expensive and less predictable customer-acquisition environment. Weaker subscriber growth and higher advertising costs can reduce contribution margins, while the lowered outlook signals that the pressure is affecting near-term business expectations.
USANA Health News
USJ FAQ
What was USANA Health’s price range in the past 12 months?
USANA Health lowest stock price was €10.50 and its highest was €26.00 in the past 12 months.
What is USANA Health’s market cap?
USANA Health’s market cap is €241.27M.
When is USANA Health’s upcoming earnings report date?
USANA Health’s upcoming earnings report date is Oct 27, 2026 which is in 47 days.
How were USANA Health’s earnings last quarter?
USANA Health released its earnings results on Aug 04, 2026. The company reported -€0.061 earnings per share for the quarter, missing the consensus estimate of €0.373 by -€0.434.
Is USANA Health overvalued?
According to Wall Street analysts USANA Health’s price is currently Overvalued.
Does USANA Health pay dividends?
USANA Health does not currently pay dividends.
What is USANA Health’s EPS estimate?
USANA Health’s EPS estimate is 0.1.
How many shares outstanding does USANA Health have?
USANA Health has 18,476,534 shares outstanding.
What happened to USANA Health’s price movement after its last earnings report?
USANA Health reported an EPS of -€0.061 in its last earnings report, missing expectations of €0.373. Following the earnings report the stock price went down -19.792%.
Which hedge fund is a major shareholder of USANA Health?
Currently, no hedge funds are holding shares in DE:USJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
USANA Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
DE:USJ Sentiment 67%
Sector Average 61%
Sector Average 61%
Insider Transactions
Sold Shares
Worth €215.7K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-50.19%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-4.26%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
USANA Health
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
USJ Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balanced clear strategic progress (strong balance sheet, stable core nutrition, successful new product launches, and retail expansion for Hiya and Rise) with meaningful near-term operational and financial headwinds (a $29M goodwill impairment for Hiya, a quarterly pre-tax loss with a $9M tax charge, lowered full-year outlook, Hiya DTC marketing pressures, and a Rise packaging disruption). Management emphasized long-term conviction and the ability to invest, but acknowledged near-term impacts to revenue, margins, and tax rates.View all DE:USJ earnings summariesTechnical Analysis
Herbalife
―
Lifeway Foods
―
Nature's Sunshine Products
―
LifeVantage
―
FitLife Brands
―